Unitree's $9 Billion IPO: China's First Humanoid Robot Maker Goes Public

When Unitree Robotics opened IPO subscriptions on the Shanghai STAR Market on August 10, 2026, it wasn’t just another Chinese tech listing. It was a watershed moment for the global humanoid robotics industry — the first time a pure-play humanoid robot maker would trade on a public exchange anywhere in the world. The company priced its shares at 150.8 yuan ($22.34) each, targeting a raise of approximately 6.1 billion yuan ($904 million) at a staggering $9 billion valuation. For a company that didn’t exist a decade ago and was founded by a single person with about $12,000 in robotics competition prize money, the trajectory is nothing short of remarkable.

From One Person to a Billion-Dollar Robot Empire

The Unitree story begins in 2016, when a young engineer named Wang Xingxing launched the company alone. “It was just me when Unitree started in 2016,” Wang recounted at the 2025 Summer Davos forum. He seeded the venture with roughly $12,000 in prize money from a robotics competition, supplemented by approximately $300,000 in angel funding. Within a decade, that modest beginning would transform into the world’s largest humanoid robot manufacturer by shipment volume — and turn its 36-year-old founder into China’s first humanoid robot billionaire, with a Forbes-estimated fortune of $2.4 billion.

What makes Wang’s ascent particularly notable is the speed. When he first appeared on the 2025 New Fortune 500 Rich List, his personal wealth was estimated at 6.69 billion yuan (roughly $930 million). Less than two years later, his net worth has surged past 18 billion yuan ($2.4 billion) — a testament to how quickly investor enthusiasm for humanoid robotics has snowballed.

The Numbers Behind the Hype

Unitree’s financials reveal a company in hypergrowth, though not without the margin pressures that come with scaling hardware production. Revenue more than quadrupled to 1.70 billion yuan (approximately $252 million) in 2025, up from 392.77 million yuan in 2024 and just 159.13 million yuan in 2023. That represents a 335% year-over-year jump — growth rates more commonly associated with software startups than hardware manufacturers.

The humanoid robot segment has become the company’s growth engine. In 2025, humanoid robots generated 867.8 million yuan (about $129 million) in revenue, accounting for 51.5% of total sales and overtaking Unitree’s legacy quadrupedal robot business for the first time. The company shipped over 5,500 humanoid robots in 2025 — the highest volume of any manufacturer globally. Between 2023 and 2025, cumulative humanoid shipments continued to accelerate as Unitree expanded its product lineup.

The quadrupedal robot line, which includes the robot dogs that first put Unitree on the map, also grew substantially. Revenue from quadrupedal robots expanded from 119 million yuan to 698 million yuan over the same multi-year period, demonstrating that demand spans both form factors.

Profitability remains solid despite aggressive reinvestment. Unitree reported a gross profit margin above 60% and an adjusted net profit of approximately $89 million in 2025. However, first-quarter 2026 results show the trade-offs of scaling: revenue rose 68.5% year-over-year to 422.8 million yuan, but profit excluding one-off items fell 52.6% to 40.3 million yuan as the company ramped up R&D and production capacity spending.

The Product Lineup

Unitree’s commercial success rests on two main humanoid platforms. The H1-2 is a full-size humanoid robot standing approximately 178 cm tall and weighing about 70 kg, equipped with 3D LiDAR, depth cameras, and Intel i5/i7 processors. With a maximum knee torque of 360 N·m and hip/waist torque of 220 N·m, the H1-2 is designed for research, industrial applications, and environments that require navigating spaces built for humans. It carries a price tag of approximately $90,000.

The G1, by contrast, is Unitree’s entry-level humanoid — a more compact platform at 127 cm tall and about 35 kg, priced from $13,500 to $16,000. With 23 to 43 joint motors depending on configuration, the G1 made headlines as one of the most affordable full humanoid robots on the market and became a viral sensation online. Unitree’s robots have been featured in widely shared videos performing backflips, boxing routines, and coordinated dance sequences — content that has been as important to the brand’s global visibility as the hardware itself.

The Valuation Question

At 150.8 yuan per share, Unitree is priced at approximately 219 times its 2025 earnings — a multiple that would seem astronomical in almost any other industry. For the first half of 2026, the prospectus guides to revenue of 1.05 to 1.13 billion yuan, suggesting annualized growth that would push the company past 2 billion yuan in revenue for the full year.

The pricing reflects an enormous bet on the future of humanoid robotics. Investors are essentially paying for the expectation that Unitree will capture a dominant share of a market that analysts project could reach tens of billions of dollars annually within the next decade. The company’s 51.5% humanoid revenue mix, combined with its position as the world’s largest humanoid shipper, gives it a credible claim to market leadership — at least for now.

But the premium valuation also raises questions about sustainability. Profit margins are compressing as production scales, competition from both Chinese rivals like Agibot and international players like Figure AI and Tesla’s Optimus is intensifying, and the ultimate commercial use cases for humanoid robots remain in early-stage development. Most of Unitree’s current customers are research institutions, universities, and technology enthusiasts rather than the industrial and enterprise buyers that would need to drive volume for the thesis to play out.

Why This IPO Matters

Unitree’s public listing is significant beyond the company itself for several reasons.

First, it provides the first real public-market price discovery for the humanoid robotics sector. Until now, valuations for companies like Figure AI, Agility Robotics, and Apptronik have been set in private funding rounds, where information is limited and investor access is restricted. A publicly traded humanoid robot maker means analysts, institutional investors, and retail participants can now evaluate the sector with standardized financial disclosures.

Second, it signals that Chinese capital markets are positioning themselves as the financing venue of choice for the robotics industry. The Shanghai STAR Market — China’s tech-focused exchange modeled loosely on Nasdaq — has aggressively courted advanced manufacturing and AI companies, and Unitree’s successful listing is likely to accelerate a pipeline of robotics IPOs. Multiple Chinese robot makers, including Agibot, Jeep Robotics, and UV Tech, are reportedly racing toward their own public offerings.

Third, it underscores the bifurcation in the global humanoid robotics race. While American companies like Tesla, Figure, and Boston Dynamics dominate headlines, Chinese manufacturers are winning on volume and price. Unitree’s ability to ship a functional humanoid for under $16,000 is a pricing advantage that Western competitors have not come close to matching, and it reflects China’s broader strengths in manufacturing scale, supply chain integration, and cost engineering.

Looking Ahead

The IPO proceeds will be directed toward expanding production capacity, accelerating R&D, and developing next-generation robot platforms. Wang Xingxing has indicated ambitions to move beyond research and entertainment applications into industrial deployment — factory floors, logistics warehouses, and eventually consumer households.

The humanoid robotics industry remains in its commercial infancy. Globally, fewer than 20,000 full humanoids were shipped in 2025 by all manufacturers combined. The market is a fraction of the size that bulls predict, and the gap between today’s capabilities and the autonomous, general-purpose robots of science fiction remains vast. But Unitree’s $9 billion IPO is the clearest signal yet that capital markets believe the industry has crossed an inflection point — and that at least one company has demonstrated enough real-world traction to justify a public bet.

For Wang Xingxing, who started building robots alone in 2016, the listing marks the beginning of a new kind of test. Building a billion-dollar company from scratch was the easy part. Delivering on a $9 billion valuation in a nascent industry with soaring competition and uncertain demand — that will be the real challenge.